PepGen Inc. (PEPG)
3.78
-0.15
(-3.82%)
USD |
NASDAQ |
Nov 20, 16:00
3.78
0.00 (0.00%)
After-Hours: 16:15
PepGen Total Liabilities (Quarterly) : 24.71M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 24.71M |
| June 30, 2026 | 21.86M |
| March 31, 2026 | 22.32M |
| December 31, 2025 | 26.46M |
| September 30, 2025 | 26.92M |
| June 30, 2025 | 31.08M |
| March 31, 2025 | 35.59M |
| December 31, 2024 | 32.26M |
| September 30, 2024 | 32.78M |
| June 30, 2024 | 38.47M |
| March 31, 2024 | 28.00M |
| December 31, 2023 | 34.63M |
| Date | Value |
|---|---|
| September 30, 2023 | 38.41M |
| June 30, 2023 | 34.80M |
| March 31, 2023 | 36.20M |
| December 31, 2022 | 37.81M |
| September 30, 2022 | 15.52M |
| June 30, 2022 | 20.58M |
| March 31, 2022 | 16.29M |
| December 31, 2021 | 10.55M |
| September 30, 2021 | 9.479M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.868M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 45.56M |
| IRulya Therapeutics, Inc. | 28.37M |
| Q32 Bio, Inc. | 9.531M |
| Bridgebio Oncology Therapeutics, Inc. | 52.84M |
| Oncolytics Biotech, Inc. | 13.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.78M |
| Shareholders Equity (Quarterly) | 103.07M |
| Debt to Equity Ratio | 0.1514 |
| Current Ratio | 8.702 |
| Net Debt Paydown Yield | 0.27% |